Anti Cardiolipin IgG at Test Zone Diagnostic Center

Anti Cardiolipin IgG at Test Zone Diagnostic Center

The Anti Cardiolipin IgG test is a specialized immunological assay used to detect and quantify IgG class autoantibodies directed against cardiolipin, a key phospholipid component of cell membranes and mitochondrial structures. At Test Zone Diagnostic Center, this highly precise laboratory investigation plays a pivotal role in diagnosing and managing systemic autoimmune conditions, most notably Antiphospholipid Syndrome (APS). Cardiolipin antibodies (aCL) are abnormal proteins produced by an overactive immune system that mistakenly target the body’s own lipids and proteins, leading to an increased risk of inappropriate blood clot formation (thrombosis), thrombocytopenia, and severe pregnancy-related complications.

Understanding the clinical significance of the IgG isotype is crucial. While anti-cardiolipin antibodies can exist in IgG, IgM, and IgA classes, the IgG isotype is clinically recognized as having the strongest correlation with thrombotic events and obstetric pathologies. When these antibodies bind to cardiolipin in the presence of cofactors like beta-2 glycoprotein I, they activate endothelial cells, platelets, and monocytes. This cascade shifts the vascular environment toward a prothrombotic state, predisposing patients to deep vein thrombosis (DVT), pulmonary embolism, stroke, and placental infarction. By utilizing state-of-the-art Enzyme-Linked Immunosorbent Assay (ELISA) technology, Test Zone Diagnostic Center provides clinicians with highly accurate quantitative measurements of these antibodies, measured in GPL units, to guide critical therapeutic decisions.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the Anti Cardiolipin IgG test at Test Zone Diagnostic Center is straightforward, as it is a standard venipuncture procedure. Patients are advised to follow these guidelines to ensure optimal sample quality and accurate clinical correlation:

• No Fasting Required: Fasting is generally not necessary for this specific immunological test. Patients can eat and drink normally prior to sample collection.
• Medication Disclosure: It is imperative to inform your healthcare provider and the laboratory staff of all medications you are currently taking. Anticoagulants (such as warfarin, heparin, or direct oral anticoagulants) do not directly interfere with the ELISA assay itself, but they are critical for the clinical interpretation of your overall coagulation profile.
• Hydration: Drinking plenty of water before the test is highly recommended, as proper hydration makes venipuncture easier by expanding blood volume and making veins more accessible.
• Infection Status: Inform the clinical team if you have recently had an acute viral or bacterial infection, as transient anti-cardiolipin antibodies can sometimes appear temporarily during or immediately after an infection.

During the Procedure

At Test Zone Diagnostic Center, patient comfort, safety, and sterile technique are our top priorities. The venipuncture process is executed by highly trained phlebotomists and follows a strict clinical protocol:

• Patient Identification and Verification: The phlebotomist will first verify your identity using at least two unique identifiers (such as your name and date of birth) to ensure absolute accuracy in labeling and tracking.
• Site Selection and Preparation: You will be comfortably seated. The phlebotomist will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the bend of the elbow). The selected site is then thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry.
• Venipuncture: A tourniquet is applied to the upper arm to increase venous pressure, making the vein more visible and palpable. A sterile, single-use needle is gently inserted into the vein. You may feel a brief, mild pinch.
• Sample Collection: Blood is drawn into a serum separator tube (SST) or a plain red-top tube. Once the required volume of blood is collected, the tourniquet is released, the needle is smoothly withdrawn, and a sterile cotton ball or gauze is applied to the puncture site with gentle pressure to stop any bleeding.
• Post-Procedure Care: A small adhesive bandage is placed over the site. You will be advised to keep the bandage on for a few hours and avoid heavy lifting with that arm for the rest of the day. The entire process takes less than five minutes.

When is an Anti Cardiolipin IgG Performed?

Evaluation of Antiphospholipid Syndrome (APS)

Physicians request the Anti Cardiolipin IgG test when they suspect Antiphospholipid Syndrome, a systemic autoimmune disorder. Under the international Sapporo/Sydney classification criteria, the persistent presence of anti-cardiolipin IgG antibodies in the blood, confirmed by a second positive test at least 12 weeks later, is a fundamental laboratory requirement for diagnosing APS. This evaluation is critical for patients exhibiting signs of systemic autoimmune diseases like Systemic Lupus Erythematosus (SLE), as secondary APS frequently coexists with these conditions.

Investigation of Recurrent Pregnancy Loss

Obstetricians routinely order this test for women who have experienced unexplained recurrent pregnancy losses. Specifically, clinical guidelines recommend screening after three or more unexplained consecutive spontaneous abortions before the 10th week of gestation, one or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week, or premature births before the 34th week due to severe preeclampsia, eclampsia, or placental insufficiency. Detecting IgG antibodies helps identify obstetric APS, allowing for timely intervention with low-dose aspirin and heparin therapy in subsequent pregnancies.

Unexplained Blood Clots (Thrombosis)

When a patient presents with unexplained thrombotic events, particularly at a young age (under 50) or in unusual anatomical locations, clinicians suspect an underlying hypercoagulable state. Symptoms such as sudden swelling and pain in a single limb (suggestive of deep vein thrombosis) or acute shortness of breath and chest pain (suggestive of pulmonary embolism) warrant an immediate workup. The Anti Cardiolipin IgG test helps determine if an autoimmune-mediated thrombophilic state is the primary driver behind these life-threatening clotting events.

Systemic Lupus Erythematosus (SLE) and Autoimmune Workup

Patients diagnosed with Systemic Lupus Erythematosus (SLE) or other connective tissue disorders are frequently screened for anti-cardiolipin antibodies. Approximately 30% to 40% of lupus patients test positive for these autoantibodies. Identifying the presence of the IgG isotype allows rheumatologists to risk-stratify patients, implement prophylactic measures to prevent thrombotic complications, and closely monitor vascular health.

Unexplained Prolonged Clotting Times (aPTT)

During routine pre-operative screenings or coagulation assessments, a patient may exhibit an unexplained prolongation of the activated partial thromboplastin time (aPTT) that does not correct when mixed with normal plasma (a mixing study). Because antiphospholipid antibodies interfere with the phospholipid reagents used in coagulation assays, they can paradoxically prolong clotting times in vitro while promoting thrombosis in vivo. The Anti Cardiolipin IgG test is performed alongside lupus anticoagulant testing to resolve this diagnostic paradox.

What Does an Anti Cardiolipin IgG Detect?

The Anti Cardiolipin IgG test at Test Zone Diagnostic Center is designed to detect and quantify specific autoantibodies that target cardiolipin. The test provides critical diagnostic insights by identifying several clinical findings, antibody levels, and pathological implications:

• Negative IgG Titers: Levels below 15 GPL units indicate the absence of significant anti-cardiolipin IgG antibodies, suggesting a low likelihood of APS.
• Low-Positive IgG Titers: Levels between 15 and 40 GPL units, which may represent transient elevations due to recent infections or low-grade autoimmune activity.
• Moderate to High-Positive IgG Titers: Levels exceeding 40 GPL units (or above the 99th percentile), which are strongly associated with clinical manifestations of Antiphospholipid Syndrome.
• Persistent Positivity: Confirmation of moderate-to-high titers on two separate occasions at least 12 weeks apart, confirming a chronic autoimmune state.
• Transient Positivity: Temporary elevations that resolve within 12 weeks, often triggered by viral, bacterial, or parasitic infections.
• Primary Antiphospholipid Syndrome: Detection of antibodies in patients with no other underlying autoimmune disease.
• Secondary Antiphospholipid Syndrome: Detection of antibodies in patients with established systemic lupus erythematosus (SLE) or rheumatoid arthritis.
• Increased Risk of Deep Vein Thrombosis (DVT): High titers correlate with a significantly elevated risk of venous clots in the lower extremities.
• Increased Risk of Pulmonary Embolism (PE): Association with life-threatening blood clots migrating to the pulmonary vasculature.
• Arterial Stroke Risk: Identification of a major risk factor for ischemic stroke, particularly in young adults without traditional cardiovascular risk factors.
• Myocardial Infarction Risk: Association with premature coronary artery thrombosis.
• Recurrent Early Pregnancy Loss: Strong correlation with recurrent spontaneous abortions occurring before the 10th week of gestation.
• Late-Term Fetal Demise: Association with unexplained intrauterine fetal death after the 10th week of gestation.
• Placental Insufficiency: Detection of antibodies that cause thrombosis in the placental microvasculature, leading to intrauterine growth restriction (IUGR).
• Preeclampsia Risk: Association with the early onset of severe preeclampsia or eclampsia before the 34th week of pregnancy.
• Thrombocytopenia: Identification of autoimmune-mediated platelet destruction, leading to low platelet counts.
• Livedo Reticularis: Correlation with a mottled, purplish, lace-like discoloration of the skin caused by microvascular occlusion.
• Libman-Sacks Endocarditis: Association with sterile, non-bacterial vegetations on the heart valves.
• Neurological Manifestations: Correlation with non-stroke neurological symptoms, including chorea, transverse myelitis, and cognitive impairment.
• Co-positivity with Lupus Anticoagulant: Increased diagnostic specificity for APS when both markers are positive.
• Co-positivity with Anti-Beta-2 Glycoprotein I: High-risk profile indicating multi-antibody positivity.
• Triple Positivity: Simultaneous presence of lupus anticoagulant, anti-cardiolipin, and anti-beta-2 glycoprotein I antibodies, representing the highest risk for thrombosis.
• False-Positive Syphilis Serology: Explanation for a false-positive VDRL or RPR test, as cardiolipin is used as an antigen in syphilis screening assays.
• Drug-Induced Autoantibodies: Detection of antibodies induced by medications such as chlorpromazine, procainamide, or quinidine.
• Infection-Induced Autoantibodies: Distinguishing transient antibodies associated with HIV, hepatitis C, syphilis, or malaria from autoimmune-mediated antibodies.
• Catastrophic Antiphospholipid Syndrome (CAPS) Risk: Assessment of risk for a rare, life-threatening variant of APS characterized by widespread microvascular thrombosis and multi-organ failure.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that receiving timely and accurate diagnostic results is essential for patient peace of mind and prompt clinical decision-making. Our laboratory utilizes fully automated, high-throughput immunoassay platforms to process the Anti Cardiolipin IgG test with the highest degree of precision. Typically, the turnaround time for this specialized immunological assay is within 24 to 48 hours from the time of sample collection.

Once the analysis is complete, the results undergo a rigorous multi-stage verification process supervised by our consultant pathologists. Patients are immediately notified via SMS or WhatsApp when their report is ready. Reports can be securely accessed and downloaded online through the official Test Zone Diagnostic Center web portal, eliminating the need for an extra trip to the center. Physical copies of the reports are also available at our reception desk for your convenience.

Anti Cardiolipin IgG Findings Overview

The following table provides a structured overview of the parameters evaluated during an Anti Cardiolipin IgG test, along with their clinical interpretations:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-Cardiolipin IgG Antibody Level	Negative (<15 GPL units)	Moderate to High Positive (>40 GPL units), indicating a strong association with Antiphospholipid Syndrome (APS).
Anti-Cardiolipin IgM Antibody Level	Negative (<15 MPL units)	Elevated levels, often associated with acute phase responses, recent infections, or early-stage autoimmune activity.
Lupus Anticoagulant Screen	Screen Negative / Normal clotting times	Screen Positive / Prolonged clotting times that do not correct with normal plasma mixing studies.
Anti-Beta-2 Glycoprotein I IgG	Negative (<20 U/mL)	Positive (>20 U/mL), confirming a highly specific autoimmune antiphospholipid profile.
Platelet Count	Normal (150,000 – 450,000 /µL)	Thrombocytopenia (<150,000 /µL), indicating autoimmune-mediated platelet clearance.
Activated Partial Thromboplastin Time (aPTT)	Normal range (typically 25-35 seconds)	Prolonged aPTT due to antibody interference with phospholipid reagents in the test tube.
Clinical History of Thrombosis	No history of arterial or venous thrombotic events	Documented history of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, or arterial occlusion.
Obstetric History	No unexplained pregnancy losses or premature births	Recurrent early miscarriages, late-term fetal loss, or severe preeclampsia before 34 weeks of gestation.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for Anti Cardiolipin IgG?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, technologists, and phlebotomists who specialize in advanced immunological testing.
• Patient-Focused Care: We prioritize your comfort and well-being, ensuring a smooth, stress-free, and virtually painless sample collection experience.
• Quality Diagnostic Services: Test Zone Diagnostic Center adheres to stringent internal and external quality control protocols to guarantee the highest level of accuracy.
• Professional Reporting: Our reports are comprehensive, easy to read, and include clear reference ranges to assist your physician in making precise clinical decisions.
• Modern Diagnostic Approach: We utilize state-of-the-art automated ELISA and chemiluminescent platforms to eliminate human error and enhance testing precision.
• Comfortable Environment: Our diagnostic center maintains a clean, hygienic, and welcoming environment designed with patient safety and comfort in mind.
• Convenient Location: Easily accessible with ample parking, making it convenient for patients to visit for sample collection.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable, evidence-based diagnostic insights that you and your doctor can trust.